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Objective: To assess the prevalence of soft bipolar features in a sample of women with postpartum
depressive symptoms, as well as to compare the sociodemographic and obstetric characteristics
of subjects with bipolar or unipolar postpartum depressive symptomatology.
Methods: Four hundred and thirty-four participants were enrolled in this cross-sectional study.
Postpartum depression (PPD) symptoms were assessed using the Edinburgh Postnatal Depression
Scale (EPDS), while the Mood Disorder Questionnaire (MDQ) was used to screen for bipolarity
features.
Results: Of the 434 participants, 66 (15.2%) scored X 13 points on the EPDS, thus fulfilling the
screening criteria, and 103 scored X 7 points on the MDQ. In comparison with non-depressed
subjects, the women who scored positively on the EPDS were significantly more likely to exhibit
symptoms of bipolar spectrum disorders (38 vs. 21%; chi-square test, p = 0.015). Women with bipolar
PPD symptomatology were significantly younger than those exhibiting unipolar PPD symptoms
(31.064.8 years vs. 28.564.1 years; t-test, p = 0.03). The groups did not differ in terms of obstetric
characteristics.
Conclusion: Our findings suggest that patients with PPD symptomatology may be more likely to
exhibit soft bipolarity features as compared with non-depressed women.
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Introduction
Postpartum depression (PPD) is a significant public health
concern,1,2 affecting approximately 10-20% of women
within the first 3 months after delivery.3 While the ICD-10
implies that PPD can only be diagnosed within the first
6 weeks postpartum,4 Sharma & Khan found that the risk
period for the disorder lasts until week 12.5
While the core symptomatology of PPD does not differ
from that of non-puerperal major depressive disorder
(MDD),6 some additional features can also be observed
(notably, low self-esteem, tension, and hypochondria7).
If left unrecognized and untreated, PPD leads to signifi-
cant morbidity, with numerous adverse outcomes, includ-
ing significant impairment for the woman, compromised
mother-infant bonding, ineffective breastfeeding, and worse
developmental outcomes in the newborn.6 It has also
been suggested that PPD is an important correlate of
suicidality among postpartum women.8
There is a substantial body of evidence to suggest that
bipolar spectrum disorders (BSD)9-11 are significantly more
prevalent among women with PPD than in the general
population.12-15 Given the fact that up to 50% of patients
with postpartum exacerbations of BSD remain mis-
diagnosed as suffering from MDD,16 some diagnostic
strategies for bipolar postnatal depression have been
proposed in recent years. According to Sharma et al.,17
bipolar PPD may be highlighted by subclinical hypomanic
symptoms during pregnancy and the postpartum period,
atypical depression, antidepressant-induced mood eleva-
tion, psychotic features, and family history of bipolar dis-
order (BD). However, in view of the paucity of evidence,
accurate diagnosis of BSD in the postnatal period remains
challenging.18 Providing affected individuals with early
and adequate treatment is crucial, as the use of anti-
depressants alone (i.e., without mood stabilizers) is known
to be a risk factor for suicide and infanticide in postpartum
women with BD.19 Within this context, the available diagnostic
and screening methods require further improvements.
Of note, Clark et al.20 and Merrill et al.21 have recently
advocated the concurrent use of the Edinburgh Postnatal
Depression Scale (EPDS)22 and the Mood Disorder
Questionnaire (MDQ)23 as an effective method of dif-
ferentiating MDD from BD in postpartum women.
The primary objective of our study was to analyze the
prevalence of bipolar symptoms (as indicated by posi-
tive MDQ scores) among Polish women with or without post-
partum depressive symptomatology (as measured with
the EPDS). We also set out to perform correlation ana-
lyses between bipolar symptoms and PPD symptomatology.
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To minimize the risk of spectrum bias,24 we focused
solely on puerperal women with no psychiatric history. As
a secondary objective, we compared the sociodemo-
graphic characteristics of subjects with bipolar or unipolar
PPD symptomatology.
Methods
Study design, setting, and participants
We recruited inpatients aged X 18 years who had recently
delivered babies in the obstetric wards of five hospitals
located in the Lesser Poland region (four hospitals in
Kraków and one in Tarnów). Enrollment was underway
between November 2009 and February 2013. At baseline,
prior to inclusion in the study, staff members provided
the patients with detailed information about the methods
and objectives of the trial. All participants signed informed
consent forms. At discharge, the participants were pro-
vided with sets of self-rating questionnaires to be filled in
between 6 and 12 weeks postpartum and mailed back to
the primary investigator (RRJ). The time frame chosen here
strikes a balance between the ICD-10 diagnostic criteria
for PPD4 and the clinical findings5 (as outlined in the
Introduction).
We applied the following exclusion criteria: personal
history of severe mental illness (including BD) and/or
psychiatric treatment, delivery of a stillborn child, life-
threatening condition in the newborn, and severe medical
comorbidities. The clinical interviewers assessed whether
the approached patients met any of the exclusion criteria.
The study protocol was approved by the Bioethics
Committee of the Jagiellonian University Medical College
(Kraków, Poland; decision no. KBET/160/B/2009).
Measurements
Edinburgh Postnatal Depression Scale (EPDS)
The EPDS, a self-report instrument consisting of 10 items
rated on a 0-3 scale, was used to screen for PPD sympto-
matology.22 Following the systematic review by Gibson
et al.,25 we adopted the cutoff score of 13 points.
Mood Disorder Questionnaire (MDQ)
The MDQ was used to screen for DSM-IV-defined BSD
(i.e., BD type I, BD type II, and BD not otherwise speci-
fied). As suggested in the original study by Hirschfeld
et al.,23 this tool can be utilized as a case-finding instru-
ment in trials encompassing subjects with a lifetime
history of mania or hypomania.
The MDQ consists of three parts26:
- A 13-item checklist of hypomanic signs. The consecu-
tive questions are intended to reflect the two dimensions
of hypomania: energized-activity (E/A; items 3, 5, 8, 9,
and 10) and irritable-racing thoughts (I/R; items 2, 6, 7, 12,
and 13). The first item (mood elevation) is thought to be
the least specific, and is hence not included in the
subcategories.
- Symptom clustering.
- An item referring to symptom-related impairment.
We applied both the original MDQ criteria23 and modi-
fied ones (by setting the screening benchmark at seven
positive responses to section-1 items while excluding
divisions 2 and 3). Use of the modified MDQ criteria in
screening for BD in community-based samples of preg-
nant and postpartum women was recently advocated by
Frey et al.27
Statistical analysis
Pearson’s rank correlation analysis was used to assess
correlations between symptoms of PPD and bipolar symp-
toms. The chi-square test was used to analyze associa-
tions between PPD and BSD symptomatology. A two-tailed
Student’s t-test and the Mann-Whitney U test were used
to compare population means.
The threshold of statistical significance was set at
p p 0.05.
Statistical analyses were performed in SPSS version
20 and Statistica version 10.
Results
Out of 607 women approached, 124 refused to take part
in the study, 23 were lost to follow-up, and 26 met at least
one of the exclusion criteria. Overall, the questionnaires
were completed by 434 subjects, for a participation rate of
71.5%. Table 1 shows the general sociodemographic and
obstetric characteristics of the study sample.
Altogether, 66 out of 434 participants met the EPDS
screening criteria (15.2%), while 103 women scored
X 7 points on the MDQ (23.7%). The original MDQ
screening criteria23 were met by 20 subjects (4.6%).
Association analysis revealed that women with PPD
symptoms were significantly more likely to exhibit bipolar
symptoms (Table 2). There was also a significant positive
correlation between EPDS and MDQ scores (Pearson’s
correlation coefficient = 0.222; p o 0.01); Figure 1 shows
the scatter plot.
In terms of sociodemographic differences, the women
with bipolar PPD symptomatology were significantly younger
than subjects exhibiting unipolar PPD symptoms. There
were no differences in any of the obstetric variables
(Table 3).
Discussion
In line with our preliminary results,28 the final report of
this study suggests that bipolar symptoms may be more
prevalent in women with postpartum depressive symp-
toms as compared to non-depressed mothers.
Our study indicates that women with postpartum depres-
sive symptomatology are significantly more likely to exhibit
bipolar symptoms. This finding remains consistent with
previous trials performed in Canada,5,14 the U.S.,15,21,29
Poland,13,30 and South Korea.31 In the bigger picture, this
conclusion is congruous with the large body of evidence
which suggests that about 25-40% of patients with MDD
actually present with subthreshold hypomanic symp-
toms.32 This issue was addressed in the DSM-5 by
adding a category of MDD with mixed features, which
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requires the presence of three or more hypomanic or
manic symptoms accompanying a major depressive
episode.33
From a pathophysiological standpoint, this finding
of high prevalence of bipolar symptoms in women with
PPD symptoms remains in line with the ample evi-
dence that supports a triggering role of childbirth in BD
exacerbations.34-36 Also, the results of this study add to
the existing body of data suggesting that younger age of
onset may denote bipolar depression.37,38
Following up-to-date clinical guidelines, we performed
EPDS screening between 6 and 12 weeks postpartum.39
The point prevalence of PPD symptoms observed over
this period (15.2%) remains consistent with the current
epidemiological data on the incidence of PPD during the
initial 12 weeks postpartum, ranging from 2.940 to
16.5%41 (with pooled estimates of 7.1-13% for unipolar
PPD3,42).
While the EPDS is both a recognized tool for facilitat-
ing diagnosis of PPD4,43 and a proxy measure for the
disorder (commonly used in clinical trials44), one shall
remember that a positive score may denote a wide range
of mental health problems.45,46 In a study encompassing
a large sample of women admitted to an obstetrical
hospital, Wisner et al.47 found that MDD and generalized
anxiety disorder were the most prevalent primary diag-
noses among participants who obtained positive scores
on the EPDS (68.5 and 52.2%, respectively), followed by
BSD (22.6%). Notably, over 80% of women diagnosed
with unipolar depressive disorders had comorbid anxiety
disorders. The fact that the EPDS consists of two sec-
tions, covering symptoms of both depression (items 1, 2, 6-10)
and anxiety (items 3-5),48 may further contribute to the
prevalence of false-positive results.49 Therefore, in clinical
practice, the EPDS should be used as an auxiliary tool,
‘‘alongside professional judgement and clinical inter-
view.’’39 In the broader picture, however, controversies
around the possible interpretations of EPDS outcomes
seem to reflect a larger discussion about the validity of
PPD as a separate disorder rather than a spectrum of
disorders.50,51
Nevertheless, the potential benefits from widespread
use of the EPDS should not be underestimated, as EPDS
screening has been shown to lead to significantly greater
reductions in psychiatric morbidity among young mothers
as compared to women screened by clinical assessment.52
The original MDQ screening criteria for bipolarity23 were
met by 4.6% of our participants. This figure is marginally
higher in comparison to the results of previous population-
based studies (ranging from 2.5 to 3.7%),53-56 suggest-
ing that BSD meeting the DSM-IV-TR criteria may be
more prevalent in postpartum women than in the general
population. When modified MDQ criteria were applied,27
the ratios of positive scores were remarkably high (23.9%
for the cutoff score of 7 points), highlighting the afore-
mentioned heterogeneity of community-based data on the
prevalence of BSD.28
To minimize the impact of spectrum bias, we decided to
exclude patients with a history of severe mental illness or
psychiatric treatment. In doing so, we followed the advice
Table 1 Sociodemographic and obstetric features of the
study population (n=434)
Variable
Sociodemographic data
Age, mean 6 SD 30.264.3 years
Age, range 20-43 years
Education
Primary 2 (B0.5)
Vocational 29 (B6.5)
Secondary 105 (24)
Higher 298 (69)
Employment status
Self-employed 53 (12)
Working full-time 285 (66)
Working part-time 28 (6)
Unemployed 47 (11)
Students 9 (B2)
Pensioners 5 (1)
Both studying and working 7 (B2)
Marital status
Married 391 (90)
Divorced 3 (B1)
Civil partnership 32 (7)
Single 8 (B2)
Place of abode
City, population 4 500,000 216 (50)
City, population 100-500,000 36 (8)
City, population 50-100,000 14 (3)
City, population 20-50,000 32 (B8)
City, population p 20,000 19 (4)
Village 117 (27)
Obstetric data
Pregnancy duration, mean 6 SD 38.962.7 weeks
Primiparity 237 (55)
Number of previous pregnancies
1 123 (28)
2 49 (11)
3 14 (3)
4 7 (2)
5 3 (B0.7)
6 1 (B0.3)
Apgar score, mean 6 SD 9.5860.92
Perceived severity of delivery, mean 6 SD* 4.9663.01
Spontaneous vaginal delivery 280 (65)
Cesarean section 154 (35)
Prolonged delivery 58 (13)
Premature delivery 123 (28)
Subdural anesthesia/analgesia 84 (19)
Data presented as n (%), unless otherwise specified.
SD = standard deviation.
*Rated on a 0-10 visual analog scale.
Table 2 Ratios of bipolar symptoms (MDQ) in women with or without postpartum depressive symptomatology (EPDS)
EPDS o 13 pts. EPDS X 13 pts. w2 p-value
MDQ o 7 pts. 290 41 8.61 0.003
MDQ X 7 pts. 78 25
EPDS = Edinburgh Postnatal Depression Scale; MDQ = Mood Disorder Questionnaire.
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of Montori et al.,24 who emphasized that enrolling ‘‘both
patients in whom the disease is unequivocally advanced
and patients who are unequivocally free of disease’’ into a
diagnostic test study may hamper its reliability, as in
clinical practice one does not make differential diagnoses
in patients lacking any diagnostic uncertainty. The authors
went on to conclude that ‘‘the ‘right’ population for a
diagnostic test study includes (1) those in whom we are
uncertain of the diagnosis; (2) those in whom we will use
the test in clinical practice to resolve our uncertainty; and
(3) patients with the disease who have a wide spectrum of
severity and patients without the disease who have
symptoms commonly associated with it.’’24 The sample
enrolled in our study seems to meet the above-delineated
assumptions, thus improving the generalizability of the
findings. As reported in the recent Cochrane review by
Molyneaux et al.,57 this approach in widely adopted in con-
temporary studies of postpartum depressive symptomatology.
Figure 1 Scatter plot of Edinburgh Postnatal Depression Scale (EPDS) scores against Mood Disorder Questionnaire (MDQ)
scores in the sample of women between 6 and 12 weeks postpartum.
Table 3 Sociodemographic and obstetric features of women with presumed unipolar or bipolar postpartum depressive
symptomatology
Unipolar*
(n=41)
Bipolarw
(n=25)
Statistics
t df p-value
Quantitative variables
Age, mean 6 SD 31.0264.81 28.4864.14 2.19 64 0.03=
Duration of pregnancy (weeks), mean 6 SD 39.2361.65 39.1963.35 0.06 58 0.95
Apgar score, sum of ranks 1,060 710 385.00 0.48
Perceived severity of delivery, sum of ranksy 1,030.50 680.50 355.50 0.37
w2 p-value
Qualitative variables, n (%)
Place of abode
City or a town 32 (78) 16 (64) 0.918 0.34
Village 9 (22) 9 (36)
Primiparous 24 (58) 19 (76) 1.38 0.24
Non-primiparous 17 (42) 6 (24)
Spontaneous vaginal delivery 21 (51) 18 (72) 1.98 0.16
Cesarean section 20 (49) 7 (28)
Prolonged delivery 3 (7) 3 (12) 0.04 0.84
Normal duration of delivery 38 (93) 22 (88)
Subdural anesthesia/analgesia during labor 8 (19) 5 (20) 0.002 0.96
No anesthesia/analgesia during labor 33 (81) 20 (80)
df = degrees of freedom; EPDS = Edinburgh Postnatal Depression Scale; MDQ = Mood Disorder Questionnaire; SD = standard deviation.
*EPDS X 13 points and MDQ o 7 points; w EPDS X 13 points and MDQ X 7 points.
= p o 0.05 denotes statistical significance.
yRated on a 0-10 visual analog scale.
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The main limitation of our study derives from the
indirectness of the findings, as we used self-rating
questionnaires and screening tests (EPDS and MDQ)
instead of structured clinical interviews.58 The observa-
tional design of the trial yields a higher risk of prognostic
imbalance.59 Also, the relatively low number of partici-
pants who met the original MDQ criteria may have
hampered the precision of our estimation,60 and the low
number of patients who met the exclusion criteria (n=26)
may suggest an impact of selection bias (a recognized
limitation in observational studies in general59). On the
other hand, the large sample size is an important advan-
tage of our study, diminishing the risk of type II errors.61
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